Gland Pharma Ltd.

BSE: 543245 | NSE: GLAND |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE068V01023 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

Gland Pharma L Gland Pharma Ltd. | BSE 1679.75 -13.10 (-0.77%) | NSE 1678.60 -13.30 (-0.79%) | Trade | Add

BSE Live

Dec 12, 16:01

1679.75 -13.10 (-0.77%)

Volume

AVERAGE VOLUME

5-Day

12,382

10-Day

13,011

30-Day

18,652

3,332

Prev. Close

1692.85
Open Price

1686.05

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)

NSE Live

Dec 12, 16:00

1678.60 -13.30 (-0.79%)

Volume

AVERAGE VOLUME

5-Day

514,802

10-Day

413,901

30-Day

372,421

172,618

Prev. Close

1691.90
Open Price

1706.80

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
1678.60 (61)

Financials

Print/Copy to Excel : Go

Profit & Loss account of Gland Pharma (in Rs. Cr.)	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
	12 mths	12 mths	12 mths	12 mths	12 mths
INCOME
Revenue From Operations [Gross]	4,083.27	4,144.44	3,583.79	4,384.15	3,423.64
Less: Excise/Sevice Tax/Other Levies	0.00	0.00	0.00	0.00	0.00
Revenue From Operations [Net]	4,083.27	4,144.44	3,583.79	4,384.15	3,423.64
Total Operating Revenues	4,116.15	4,167.43	3,616.53	4,400.71	3,462.88
Other Income	215.08	166.67	240.46	223.94	134.78
Total Revenue	4,331.22	4,334.09	3,856.99	4,624.65	3,597.65
EXPENSES
Cost Of Materials Consumed	1,706.24	1,826.94	1,716.75	2,046.86	1,749.16
Purchase Of Stock-In Trade	14.49	23.14	15.59	25.67	16.20
Operating And Direct Expenses	0.00	0.00	124.84	95.05	74.59
Changes In Inventories Of FG,WIP And Stock-In Trade	130.25	87.43	-46.92	36.69	-273.49
Employee Benefit Expenses	439.02	409.95	399.70	338.57	311.36
Finance Costs	22.84	7.84	7.41	5.24	3.41
Depreciation And Amortisation Expenses	169.27	162.11	146.74	110.30	98.78
Other Expenses	383.53	411.20	388.01	347.23	282.79
Total Expenses	2,865.64	2,928.60	2,752.13	3,005.61	2,262.80
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax	1,465.59	1,405.50	1,104.86	1,619.04	1,334.85
Exceptional Items	0.00	0.00	-56.46	0.00	0.00
Profit/Loss Before Tax	1,465.59	1,405.50	1,048.40	1,619.04	1,334.85
Tax Expenses-Continued Operations
Current Tax	365.48	341.02	276.19	395.88	339.45
Less: MAT Credit Entitlement	0.00	0.00	0.00	0.00	0.00
Deferred Tax	9.12	24.68	-2.80	14.01	0.12
Tax For Earlier Years	1.23	-3.53	-0.82	-3.00	-1.72
Total Tax Expenses	375.83	362.17	272.58	406.89	337.85
Profit/Loss After Tax And Before ExtraOrdinary Items	1,089.75	1,043.33	775.83	1,212.16	997.01
Profit/Loss From Continuing Operations	1,089.75	1,043.33	775.83	1,212.16	997.01
Profit/Loss For The Period	1,089.75	1,043.33	775.83	1,212.16	997.01
OTHER ADDITIONAL INFORMATION
EARNINGS PER SHARE
Basic EPS (Rs.)	66.15	63.35	47.12	73.84	63.07
Diluted EPS (Rs.)	66.15	63.35	47.11	73.67	62.99
VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS
Imported Raw Materials	0.00	0.00	0.00	0.00	0.00
Indigenous Raw Materials	0.00	0.00	0.00	0.00	0.00
STORES, SPARES AND LOOSE TOOLS
Imported Stores And Spares	0.00	0.00	0.00	0.00	0.00
Indigenous Stores And Spares	0.00	0.00	0.00	0.00	0.00
DIVIDEND AND DIVIDEND PERCENTAGE
Equity Share Dividend	329.50	0.00	0.00	0.00	0.00
Tax On Dividend	0.00	0.00	0.00	0.00	0.00
Equity Dividend Rate (%)	1,800.00	2,000.00	0.00	0.00	0.00